Transcatheter Tricuspid Valve-In Implantation With a Novel Balloon Expandable Myval Thv
No Thumbnail Available
Date
2021
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier Science inc
Open Access Color
OpenAIRE Downloads
OpenAIRE Views
Abstract
The transcatheter tricuspid valve-in-valve implantation has not yet been clarified, and several case series have documented results in patients with tricuspid bioprosthetic valve degeneration who underwent transcatheter implantation of Edwards SAPIEN XT and SAPIEN 3 (Edwards Lifesciences, Irvine, CA) and Medtronic (Minneapolis, MN) valves. Here, we present the case of a patient with severe bioprosthetic tricuspid valve stenosis who was successfully treated with the transfemoral route through the 29-mm novel balloon expandable Myval transcatheter heart valve (Meril Life Sciences Pvt Ltd, Vapi, Gujarat, India) system. (C) 2021 by The Society of Thoracic Surgeons
Description
AYHAN, Hüseyin/0000-0002-9991-7307
ORCID
Keywords
[No Keyword Available]
Turkish CoHE Thesis Center URL
Fields of Science
Citation
WoS Q
Q1
Scopus Q
Source
Volume
112
Issue
6
Start Page
E435
End Page
E437